Prominent publications by Camil Castelo‐Branco

KOL Index score: 13340

OBJECTIVE: To determine the effects of menopause and three different formulations of E2 plus medroxyprogesterone acetate on serum concentrations of basal and growth hormone-releasing hormone (GHRH)-stimulated growth hormone (GH), insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein (IGFBP)-1, IGFBP-3, insulin, and C peptide.

DESIGN: Prospective, controlled trial.

SETTING: Menopausal outpatient clinic at an academic tertiary care hospital.

PATIENT(S): Nineteen ...

Also Ranks for: Growth Hormone |  binding protein |  postmenopausal women |  gh igf1 |  igfbp1 igfbp3
KOL Index score: 13116

BACKGROUND: Metabolic syndrome (METS) is a strong predictor of cardiovascular risk. Since the prevalence of METS increases after menopause, gynecological routine consultation offers an excellent screening opportunity.

OBJECTIVES: To assess the prevalence of METS in Latin American postmenopausal women and factors modifying its risk; as well as to assess the role of simple routine care measurements in the diagnosis of the METS.

METHODS: A total of 3965 postmenopausal women, aged 45-64 ...

Also Ranks for: Metabolic Syndrome |  prevalence mets |  postmenopausal latin |  treatment panel |  atp iii
KOL Index score: 11890

OBJECTIVES: To explore clinically relevant differences in severity of vulvar and vaginal atrophy (VVA) in postmenopausal women treated with ospemifene compared with placebo.

METHODS: Analysis of two multicenter, randomized, double-blind, 12-week phase-III studies in postmenopausal women (40-80 years, with VVA, treated with ospemifene 60 mg/day or placebo (Study 310 and Study 821)). Severity of vaginal dryness and dyspareunia were evaluated using a four-point scoring system and clinically ...

Also Ranks for: Vaginal Atrophy |  ospemifene placebo |  postmenopausal women |  substantial improvement relief |  baseline week
KOL Index score: 10360

BACKGROUND: Long permanent remissions in malignant hematopoietic disorders can often be achieved by autologous bone marrow transplantation (ABMT) or by allogenic bone marrow transplantation (BMT). Previous studies have shown that such therapies may induce osteoporosis due to iatrogenic ovarian failure. The administration of hormone replacement therapy (HRT) in these women could prevent the adverse effects of long-term ovarian failure without remarkable side effects. The aim of this study ...

Also Ranks for: Bone Mass |  ovarian failure |  hormone replacement therapy |  marrow transplantation |  hematologic neoplasms
KOL Index score: 10266

BACKGROUND: The main goals of estrogen replacement therapy (ERT) are the prevention of osteoporosis and cardioprotection and the improvement of quality of life (QL). Androgens and tibolone therapy may increase bone mineral density (BMD) to a greater extent than ERT and offer an increase in QL. Lipid and cardiovascular effects, however, are still a major concern.

AIM: To evaluate whether the addition of a weak androgen to ERT may improve postmenopausal bone loss and sexual activity ...

Also Ranks for: Postmenopausal Women |  hdl cholesterol |  sexual activity |  tibolone therapy |  greater extent
KOL Index score: 9811

BACKGROUND: It is well known that progestins given in sufficient dosage reduce the risk of endometrial cancer and endometrial hyperplasia. It is also not uncommon that patients receiving hormone replacement therapy (HRT) require endometrial biopsy in order to evaluate the effects of oestrogens and progestogens on endometrium. However, endometrial biopsy is often associated with pain and discomfort, and transvaginal sonography has been suggested as a new and painless method of monitoring ...

Also Ranks for: Hormone Replacement Therapy |  transvaginal sonography |  postmenopausal women |  endometrial biopsy |  cutaneous administration
KOL Index score: 9801

OBJECTIVE: To assess the effect of the publication of the Women's Health Initiative (WHI) study on patients' and physicians' attitudes in relation to hormone therapy (HT).

DESIGN: A survey focused on the degree of knowledge and on the reactions to the WHI study was administered to 600 women allocated in two groups according to their socioeconomic status, high (HSES) or low (LSES). Additionally, 283 physicians were surveyed to determine their attitudes regarding HT after the publication ...

Also Ranks for: Whi Study |  attitudes ht |  health initiative |  physicians patients |  socioeconomic status
KOL Index score: 9589

OBJECTIVE: To investigate glyco-lipidic metabolism and androgenic profile in a cohort of women with polycystic ovary syndrome (PCOS) divided according to Rotterdam phenotypes and body mass index (BMI).

DESIGN: A prospective case-control study.

SETTING: Gynecology department in a teaching hospital. Patients. A total of 223 PCOS women and 25 healthy control women were studied.

METHODS: Patients and controls were subdivided into three groups according to their BMI: normal weight ...

Also Ranks for: Pcos Patients |  body mass bmi |  metabolic profile |  total testosterone tg |  control women
KOL Index score: 9410

OBJECTIVE: To determine the effect of vaginal progesterone as luteal support on pregnancy outcomes in infertile patients who undergo ovulation induction with gonadotropins and intrauterine insemination (IUI).

DESIGN: Prospective randomized trial.

SETTING: Tertiary referral center.

PATIENT(S): About 398 patients with primary infertility were treated during 893 ovarian stimulation and IUI cycles from February 2010 to September 2012.

METHODS: All patients underwent ovarian stimulation with ...

Also Ranks for: Luteal Phase Support |  intrauterine insemination |  vaginal progesterone |  pregnancy rate |  iui patients
KOL Index score: 9407

BACKGROUND: An important goal in menopause research is to develop knowledge and identify interventions that strive to promote, maintain and enhance well-being for women.

OBJECTIVE: To evaluate the knowledge of postmenopausal Spanish women about menopause and their knowledge of and trust in hormone replacement therapy (HRT) and to identify their sources of information and how those data are related to compliance with their prescription.

STUDY DESIGN: A total of 270 symptomatic ...

Also Ranks for: Hormone Therapy |  knowledge menopause |  menopausal women |  structured questionnaire |  patient compliance
KOL Index score: 9332

A cross-sectional survey was conducted to determine the current situation in Spain regarding diagnosis and care of patients with osteoporosis in the primary care setting. A total of 2,500 primary care physicians who were homogeneously grouped in autonomous communities throughout the country received a postal 30-item anonymous self-administered questionnaire. The questionnaire covered demographics and personal characteristics of the physicians, conditions in everyday consultation, and ...

Also Ranks for: Diagnosis Osteoporosis |  general practice |  primary physicians |  crosssectional survey |  health knowledge
KOL Index score: 9155

AIM: To evaluate with validated instruments changes in quality of life and sexuality in women receiving hormonal replacement therapy (AHT).

DESIGN: Randomised, double-blind, double-dummy study with two parallel treatment arms.

PATIENTS AND METHODS: Forty-seven healthy post-menopausal women, aged 45-64 years, were evaluated using the Female Sexual Function Index (FSFI) and the menopause-specific quality of life questionnaire (MENQOL). Of them, 40 diagnosed with sexual dysfunction were ...

Also Ranks for: Sexual Dysfunction |  hormone therapy |  quality life |  menopausal women |  conjugated estrogens
KOL Index score: 8890

OBJECTIVE: The aim of this review was to summarize the literature regarding the impact of the menopause transition on body weight and body composition.

METHODS: We conducted a search of the literature using Medline (Ovid, 1946-present) and PubMed (1966-2012) for English-language studies that included the following search terms: 'menopause', 'midlife', 'hormone therapy' or 'estrogen' combined with 'obesity', 'body weight' or 'body composition'.

RESULTS: Whereas weight gain per se cannot ...

Also Ranks for: Weight Gain |  estrogen therapy |  body composition |  abdominal fat |  menopause transition
KOL Index score: 8887

Background and objectivesTo compare effectiveness and safety of dinoprostone, misoprostol and Cook’s balloon as labour-inducing agents in women with intrauterine growth restriction (IUGR) at term.MethodsRetrospective cohort chart review of women diagnosed with foetal growth restriction at term in Reina Sofia Hospital, Cordoba, Spain from January 2014 to December 2015. Registration of baseline characteristics and method of induction was made. The main outcome was time from induction to ...

Also Ranks for: Growth Restriction |  dinoprostone misoprostol |  labour induction |  pregnancy outcome |  delivery obstetric
KOL Index score: 8884

In order to determine the prevalence of sexual dysfunction (SD) and related risk factors in a cohort of middle-aged women the Laumann's test (DSM-IV) was passed to 534 healthy women between 40 and 64 years old (mean: 52.4+/-5.7) attending the Southern Metropolitan Health Service in Santiago de Chile. Of all the women, 82.8% were peri- or postmenopausal, 23% had received hormone replacement therapy (HRT) and 79.2% were sexually active. Among those who were sexually active a total of 51.3% ...

Also Ranks for: Sexual Dysfunction |  aged women |  hormone replacement therapy |  prevalence age |  risk factors cohort

Key People For Postmenopausal Women

Top KOLs in the world
Jane * ******
hip fracture older women breast cancer
Jo *** * ******
breast cancer postmenopausal women type 2 diabetes
Steven *** ********
hip fracture breast cancer older women
Elizabeth * **************
rancho bernardo study postmenopausal women cognitive function
Marcia * *********
postmenopausal women physical activity breast cancer
Walter ********* *******
breast cancer type 2 diabetes coronary heart disease

Camil Castelo‐Branco:Expert Impact

Concepts for whichCamil Castelo‐Brancohas direct influence:Postmenopausal women,  Hormone replacement therapy,  Cyproterone acetate,  Sexual quality,  Sexual dysfunction,  Bone loss,  Replacement therapy,  Endothelial function.

Camil Castelo‐Branco:KOL impact

Concepts related to the work of other authors for whichfor which Camil Castelo‐Branco has influence:Postmenopausal women,  Menopausal symptoms,  Sexual dysfunction,  Metabolic syndrome,  Hormone therapy,  Vaginal atrophy,  Quality life.



Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain. | Faculty of Medicine - University of Barcelona, Clinic Institute of Gynecology, Obstetrics and Neonatology, Hospital Clinic - Institut d´Investigacions Biomèdiques August Pi i Sunyer